Etomidate and Vision blurred - a phase IV clinical study of FDA data

Summary:

Vision blurred is reported as a side effect among people who take Etomidate (etomidate), especially for people who are female, 50-59 old, also take Zometa, and have Bone disorder.

The phase IV clinical study analyzes which people have Vision blurred when taking Etomidate. It is created by eHealthMe based on reports of 2,491 people who have side effects when taking Etomidate from the FDA, and is updated regularly.

What is Etomidate?

Etomidate has active ingredients of etomidate. eHealthMe is studying from 2,496 Etomidate users. Check the latest studies of Etomidate.

What is Vision blurred?

Vision blurred is found to be associated with 2,495 drugs and 2,968 conditions by eHealthMe. Check the latest studies of Vision blurred.



On Jul, 22, 2026

2,491 people reported to have side effects when taking Etomidate.
Among them, 12 people (0.48%) have Vision blurred.

Could Etomidate cause Vision blurred?

Among these 12 people:

What is the gender of people who have Vision blurred when taking Etomidate? *

  • female: 100 %
  • male: 0.0 %

What is the age of people who have Vision blurred when taking Etomidate? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

What are other drugs people take besides Etomidate? *

  1. Zosyn: 12 people, 100.00%
  2. Famotidine: 12 people, 100.00%
  3. Lisinopril: 12 people, 100.00%
  4. Lasix: 12 people, 100.00%
  5. Keppra: 12 people, 100.00%
  6. Keflex: 12 people, 100.00%
  7. Flexeril: 12 people, 100.00%
  8. Fentanyl Citrate: 12 people, 100.00%
  9. Effexor: 12 people, 100.00%
  10. Zometa: 12 people, 100.00%

What are other side effects people have besides Vision blurred? *

  1. Hypotension (abnormally low blood pressure): 12 people, 100.00%
  2. Injury: 12 people, 100.00%
  3. Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs): 12 people, 100.00%
  4. Haematoma (collection of blood outside the blood vessels): 12 people, 100.00%
  5. High Blood Pressure: 12 people, 100.00%
  6. Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 12 people, 100.00%
  7. Bone Deformity: 12 people, 100.00%
  8. Blood Immunoglobulin G Decreased: 12 people, 100.00%
  9. Infection: 12 people, 100.00%
  10. Intervertebral Disc Disorder (spinal disc disorder): 12 people, 100.00%

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 3 people, 25.00%
  2. Bone Disorder: 3 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Etomidate and have Vision blurred?

- Check whether Vision blurred is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Etomidate:

Vision blurred treatments and more:

How severe was Vision blurred and when was it recovered:

Expand to all the drugs that have ingredients of etomidate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Etomidate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vision blurred:

Browse all the conditions that are associated with Vision blurred:


How the study uses the data?

The study uses data from the FDA. It is based on etomidate (the active ingredients of Etomidate) and Etomidate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: